BigBear.ai (BBAI) Stock Rallies Over 10% Ahead of May 5 Earnings Release

Key Takeaways

Table of Contents

Shares of BBAI climbed 10.9% on Tuesday with an additional 1.7% gain in pre-market trading Wednesday
Volume reached approximately 68 million shares, roughly 36% higher than typical daily activity
The company reports Q1 2026 financial results on May 5; consensus calls for a loss of $0.08 per share on revenue near $33.6M
The most bullish analyst, HC Wainwright, maintains a $6 price target representing approximately 45% potential upside
Consensus price targets ranging from $5.33 to $5.50 indicate roughly 30% upside potential from current price levels

Shares of BigBear.ai experienced significant upward movement on Tuesday, advancing 10.9% to settle near $4.14. The session saw elevated trading activity with approximately 68 million shares changing hands — substantially above the typical range of 37 to 50 million shares.

BigBear.ai Holdings, Inc., BBAI

The positive momentum extended into Wednesday’s pre-market session, where the stock added another 1.7% as the week progressed.

The upward price action doesn’t seem connected to any specific catalyst or news announcement. Rather, it appears driven by increased investor appetite for AI-powered defense analytics companies as earnings season approaches.

BBAI is scheduled to unveil its Q1 2026 financial performance on May 5. Wall Street consensus anticipates a per-share loss of $0.08, which would represent substantial improvement compared to the $0.25 loss recorded during Q1 2025.

On the revenue front, analysts are forecasting approximately $33.6 million — representing a decline of more than 3% on a year-over-year basis. The company’s previous quarterly filing revealed revenue of only $27.3 million, marking a 37.7% decrease versus the comparable prior-year period.

Despite the revenue shortfall, that most recent quarter did deliver an earnings surprise. BBAI reported a loss of $0.01 per share compared to the expected loss of $0.05, although topline results significantly missed projections.

Key Areas of Focus for Investors

Market participants will be closely monitoring contract announcements and government spending trends when the Q1 figures are published.

BBAI’s topline performance is heavily dependent on contracts with U.S. defense agencies and federal government entities. Progress on new agreements and order conversions will serve as critical indicators of whether the company is building business momentum.

Another area drawing attention is Ask Sage, the GenAI technology platform BBAI purchased for $250 million. HC Wainwright’s Scott Buck believes this acquisition could accelerate revenue growth and improve profitability metrics, characterizing it as a potentially significant contributor to 2026 financial performance.

Buck maintains the Street’s highest price objective at $6 — approximately 45% above where shares currently trade. He also highlighted the company’s cash position as providing strategic flexibility for additional acquisitions.

Wall Street Views and Shareholder Movements

Analyst coverage of BBAI remains limited. Currently, three ratings exist on the stock: one Buy recommendation, one Hold, and one Sell, with the average price objective landing between $5.33 and $5.50.

Cantor Fitzgerald reduced its price target from $6 to $5 in March while assigning a neutral stance. HC Wainwright similarly lowered its target from $8 to $6 but maintained its buy recommendation. Weiss Ratings currently has a sell rating on the shares.

Regarding institutional ownership, multiple major asset managers increased their positions during Q4. Vanguard expanded its stake by 18.4%, UBS approximately doubled its holdings, and State Street increased its position by 33.6%.

Insider activity included one notable sale in March. Board member Pamela Joyce Braden disposed of 80,000 shares at $4.00 apiece, trimming her stake by roughly 13.6%.

The company currently holds a market capitalization near $1.98 billion, exhibits a beta of 3.47, and maintains a debt-to-equity ratio of 0.16. The stock’s 50-day moving average stands at $3.75, while the 200-day average is positioned at $5.25.

Investors will receive concrete financial updates on May 5 when the company reports Q1 2026 results.

✨ Limited Time Offer